BB&T Securities’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $15.6M | Sell |
292,117
-2,821
| -1% | -$145K | 0.14% | 192 |
|
|
2019
Q2 | $14.8M | Buy |
294,938
+1,141
| +0.4% | +$57.3K | 0.13% | 206 |
|
|
2019
Q1 | $15.3M | Buy |
293,797
+10,123
| +4% | +$506K | 0.15% | 190 |
|
|
2018
Q4 | $13.5M | Sell |
283,674
-13,793
| -5% | -$679K | 0.15% | 183 |
|
|
2018
Q3 | $14.9M | Buy |
297,467
+537
| +0.2% | +$27.3K | 0.15% | 192 |
|
|
2018
Q2 | $15M | Sell |
296,930
-22,076
| -7% | -$1.11M | 0.16% | 177 |
|
|
2018
Q1 | $15.6M | Buy |
319,006
+102,132
| +47% | +$4.76M | 0.18% | 158 |
|
|
2017
Q4 | $9.62M | Sell |
216,874
-52,775
| -20% | -$2.44M | 0.13% | 226 |
|
|
2017
Q3 | $13.7M | Buy |
269,649
+38,951
| +17% | +$1.98M | 0.19% | 149 |
|
|
2017
Q2 | $12.4M | Buy |
230,698
+45,778
| +25% | +$2.44M | 0.18% | 158 |
|
|
2017
Q1 | $9.74M | Sell |
184,920
-67,516
| -27% | -$3.43M | 0.13% | 191 |
|
|
2016
Q4 | $13.5M | Sell |
252,436
-1,390
| -0.5% | -$68.7K | 0.2% | 129 |
|
|
2016
Q3 | $13.7M | Sell |
253,826
-14,653
| -5% | -$803K | 0.2% | 122 |
|
|
2016
Q2 | $14.5M | Buy |
268,479
+10,590
| +4% | +$558K | 0.23% | 113 |
|
|
2016
Q1 | $13.1M | Buy |
257,889
+55,890
| +28% | +$2.78M | 0.21% | 115 |
|
|
2015
Q4 | $10.2M | Buy |
201,999
+43,373
| +27% | +$2.21M | 0.21% | 107 |
|
|
2015
Q3 | $7.62M | Sell |
158,626
-78,742
| -33% | -$4.1M | 0.17% | 118 |
|
|
2015
Q2 | $12.4M | Buy |
237,368
+32,525
| +16% | +$1.83M | 0.26% | 88 |
|
|
2015
Q1 | $118M | Buy |
204,843
+24,976
| +14% | +$1.43M | 0.26% | 90 |
|
|
2014
Q4 | $96.1M | Buy |
179,867
+35,989
| +25% | +$2.01M | 0.22% | 98 |
|
|
2014
Q3 | $82.7M | Buy |
143,878
+14,628
| +11% | +$897K | 0.19% | 113 |
|
|
2014
Q2 | $86.4M | Buy |
129,250
+29,809
| +30% | +$2.02M | 0.21% | 100 |
|
|
2014
Q1 | $66.4M | Buy |
99,441
+6,204
| +7% | +$419K | 0.17% | 109 |
|
|
2013
Q4 | $62.2M | Buy |
93,237
+13,020
| +16% | +$844K | 0.17% | 120 |
|
|
2013
Q3 | $50.3M | Buy |
80,217
+2,859
| +4% | +$184K | 0.16% | 118 |
|
|
2013
Q2 | $48.3K | Buy |
+77,358
| New | +$4.91M | 0.16% | 118 |
|
Other funds holding GSK
BCIM
